Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ROBITUSSIN DM SYRUP - HSA Drug Approval Details

Approvals/HSA/ROBITUSSIN DM SYRUP

Approved

THERAPEUTIC

ROBITUSSIN DM SYRUP

INTERPHIL LABORATORIES INC (PHILIPPINES)🇸🇬 Health Sciences Authority

Approval Date: Mar 7, 2003
Approval ID: fbe0cb9fff7d2e81
Company: INTERPHIL LABORATORIES INC (PHILIPPINES)
Type: Therapeutic

Approval Details

Approval Id: fbe0cb9fff7d2e81
Drug Name: ROBITUSSIN DM SYRUP
Product Name: ROBITUSSIN DM SYRUP
Approval Number: SIN12222P
Approval Date: 2003-03-07
Registrant: HALEON SINGAPORE PTE. LTD.
Licence Holder: HALEON SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PHARMACY ONLY MEDICINES
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R05CA10
Atc Item Name: combinations
Pharma Manufacturer Name: gsk consumer healthcare singapore pte. ltd.

Active Ingredients

DEXTROMETHORPHAN HBr

30 mg/10 ml

GUAIPHENESIN

200 mg/10 ml

DEXTROMETHORPHAN HBr

30 mg/10 ml

GUAIPHENESIN

200 mg/10 ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 7, 2003

Approval ID

fbe0cb9fff7d2e81

Type

Therapeutic

Back to HSA Approvals